A235 A Prolonged Therapy Improves Quality of Response, and CR Associated with Superior Outcomes, with VMP

Jean‐Luc Harousseau; Rubén Niesvizky; Antonio Palumbo; Paul G. Richardson; Rudolf Schlag; Meletios A Dimopoulos; Ofer Shpilberg; Martin Kropff; M Delforge; Rik Schots; Michèle Cavo; А К Голенков; M. Komarnicki; MV Mateos; Andrew Cakana; K Liu; William Deraedt; Anthony Boral; Helgi van de Velde; Jesús F. San Miguel

doi:10.1016/s1557-9190(11)70515-7

Related publications

Article2009

A Prolonged Therapy Improves Quality of Response, and CR Associated with Superior Outcomes, with VMP

J. L. Harousseau, Rubén Niesvizky, Antonio Palumbo, PG Richardson, Rudolf Schlag, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Michel Delforge, Henri Schots, Michèle Cavo, A. Golenkov, M Komarnicki, MV Mateos, Andrew Cakana, K. Liu, William Deraedt, Andrew Boral, Ann Van de Velde, Jesús F. San Miguel

Article2009

A232 Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA

Jesús F. San Miguel, Meletios A Dimopoulos, Rudolf Schlag, Nuriet K. Khuageva, Ofer Shpilberg, Martin Kropff, Maria Teresa Petrucci, Antonio Palumbo, Olga Samoilova, Anna Dmoszyńska, Abdulkadyrov Km, Rik Schots, Baoguo Jiang, MV Mateos, KC Anderson, DL Esseltine, K Liu, Andrew Cakana, Helgi van de Velde, PG Richardson

Article2008

Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm)

Antonio Palumbo, Rudolf Schlag, Nuriet K. Khuageva, Ofer Shpilberg, Meletios A Dimopoulos, Martin Kropff, Ivan Špıčka, MT Petrucci, Michel Delforge, MV Mateos, Dixie‐Lee Esseltine, K Liu, William Deraedt, H. Van de Velde, Paul G. Richardson, JF San-Miguel

Article2020

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Paula Rodríguez‐Otero, Mario Boccadoro, Roman Hájek, Tomoaki Fujisaki, Jae Hoon Lee, Joaquín Martínez‐López, Paulo Lúcio, Zsolt Nagy, Ganna Usenko, Anna Marina Liberati, Mihaela Lazaroiu, Dariusz Woszczyk, Hiroyuki Takamatsu, Joanna Romejko‐Jarosińska, Stefan Knop, Astrid Pavlovsky, Cecily Forsyth, Takayuki Ishikawa, Katharine S. Gries, Huiling Pei, Anupa Kudva, Jon Ukropec, ,

Article2008

Superior Outcomes Associated with Complete Response: Analysis of the Phase III VISTA Study of Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone

Jean‐Luc Harousseau, Antonio Palumbo, Paul G. Richardson, Rudolf Schlag, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Michel Delforge, Rik Schots, Michèle Cavo, А К Голенков, Mieczysław Komarnicki, María‐Victoria Mateos, Andrew Cakana, Kevin Liu, William Deraedt, Helgi van de Velde, Jesús F. San Miguel